USA |NASDAQ |USD |ADR
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| May 25, 2022 | Mar 2022 | $-0.14 | $-0.30 | $0.88 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| May 25, 2022 | Mar 2022 | $2.74M | $310.00K | $14.50M |
Collplant Biotechnologies Ltd's next earnings date is Wednesday, May 25, 2022 for the fiscal quarter ending Mar 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Jun 2022 | 1 | $-0.07 | $-0.07 | $-0.07 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 1 | $-0.38 | $-0.38 | $-0.38 |
| Dec 2023 | 1 | $3.19 | $3.19 | $3.19 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Jun 2022 | 0 / 0 | $0.21 | $0.21 | $0.21 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $1.77 | $1.89 | $1.89 |
| Dec 2023 | 0 / 0 | $7.08 | $3.78 | $3.78 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Jun 2022 | 1 | $2.86M | $2.86M | $2.86M |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 1 | $11.90M | $11.90M | $11.90M |
| Dec 2023 | 1 | $70.64M | $70.64M | $70.64M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| May 25, 2022 | Mar 2022 | $-0.14 | - | - |
| Mar 24, 2022 | Dec 2021 | $-0.29 | $-0.30 | -3.45% |
| Nov 18, 2021 | Sep 2021 | $-0.27 | $-0.29 | -7.41% |
| Aug 19, 2021 | Jun 2021 | $-0.27 | $-0.30 | -11.11% |
| May 27, 2021 | Mar 2021 | $0.80 | $0.88 | 10.00% |
| Mar 26, 2021 | Dec 2020 | $-0.28 | $-0.42 | -50.00% |
| Dec 1, 2020 | Sep 2020 | $1.90 | $0.07 | -96.32% |
| Aug 28, 2020 | Jun 2020 | $-0.25 | $-0.28 | -12.00% |
| Apr 1, 2020 | Mar 2020 | $-0.13 | $-0.78 | -500.00% |
| Dec 31, 2019 | Dec 2019 | $-0.25 | $-0.25 | - |
| Nov 29, 2019 | Sep 2019 | $-0.26 | $-0.69 | -165.38% |
| Sep 26, 2019 | Jun 2019 | - | $-0.33 | - |
| Apr 1, 2019 | Mar 2019 | $0.01 | $0.01 | -50.00% |
| Mar 31, 2019 | Dec 2018 | - | $-0.29 | - |
| Nov 29, 2018 | Sep 2018 | - | $-0.01 | - |
| Sep 21, 2018 | Jun 2018 | - | $-0.36 | - |
| May 24, 2018 | Mar 2018 | - | $-0.61 | - |
| Mar 21, 2018 | Dec 2017 | - | $-0.51 | - |
| Nov 20, 2017 | Sep 2017 | - | $-0.01 | - |
| Sep 1, 2017 | Jun 2017 | - | $-0.01 | - |
| May 29, 2017 | Mar 2017 | - | $-0.01 | - |
| Mar 28, 2017 | Dec 2016 | - | $-0.02 | - |
| Nov 24, 2016 | Sep 2016 | - | $-0.05 | - |
| Aug 31, 2016 | Jun 2016 | - | $-0.02 | - |
| May 29, 2016 | Mar 2016 | - | $-0.02 | - |
| Mar 29, 2016 | Dec 2015 | - | $-0.01 | - |
| Sep 30, 2015 | Sep 2015 | - | $-0.01 | - |
| Jun 30, 2015 | Jun 2015 | - | $-0.01 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 24, 2022 | Dec 2021 | $0.32 | $-0.01 | - |
| Mar 26, 2021 | Dec 2020 | $-1.10 | $-1.41 | - |
| Dec 31, 2019 | Dec 2019 | $-0.55 | $-1.26 | - |
| Mar 31, 2019 | Dec 2018 | $0.00 | $-1.27 | - |
| Mar 21, 2018 | Dec 2017 | - | $-0.54 | - |
| Mar 28, 2017 | Dec 2016 | - | $-0.11 | - |
| Mar 29, 2016 | Dec 2015 | - | $-0.04 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| May 25, 2022 | Mar 2022 | $2.74M | - | - |
| Mar 24, 2022 | Dec 2021 | $0.00 | $310.00K | - |
| Nov 18, 2021 | Sep 2021 | $120.00K | $140.00K | 1.17% |
| Aug 19, 2021 | Jun 2021 | $691.00K | $691.00K | 1.00% |
| May 27, 2021 | Mar 2021 | $14.60M | $14.50M | 0.99% |
| Mar 26, 2021 | Dec 2020 | $280.00K | $557.00K | 1.99% |
| Dec 1, 2020 | Sep 2020 | $11.73M | $4.15M | 0.35% |
| Aug 28, 2020 | Jun 2020 | $1.54M | $823.00K | 0.53% |
| Apr 1, 2020 | Mar 2020 | $700.00K | $823.00K | 1.18% |
| Dec 31, 2019 | Dec 2019 | $700.00K | $439.00K | 0.63% |
| Nov 29, 2019 | Sep 2019 | - | $679.00K | - |
| Sep 26, 2019 | Jun 2019 | $21.12M | $606.00K | 0.03% |
| Apr 1, 2019 | Mar 2019 | $21.12M | $594.00K | 0.03% |
| Mar 31, 2019 | Dec 2018 | $4.41M | $15.79M | 3.58% |
| Nov 29, 2018 | Sep 2018 | - | $225.05K | - |
| Sep 21, 2018 | Jun 2018 | - | $178.50K | - |
| May 24, 2018 | Mar 2018 | - | $220.88K | - |
| Mar 21, 2018 | Dec 2017 | - | $442.93K | - |
| Nov 20, 2017 | Sep 2017 | - | $74.51K | - |
| Sep 1, 2017 | Jun 2017 | - | $57.63K | - |
| May 29, 2017 | Mar 2017 | - | $69.00K | - |
| Mar 28, 2017 | Dec 2016 | - | - | - |
| Nov 24, 2016 | Sep 2016 | - | $24.50K | - |
| Aug 31, 2016 | Jun 2016 | - | - | - |
| May 29, 2016 | Mar 2016 | - | - | - |
| Mar 29, 2016 | Dec 2015 | - | - | - |
| Sep 30, 2015 | Sep 2015 | - | - | - |
| Jun 30, 2015 | Jun 2015 | - | - | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 24, 2022 | Dec 2021 | $15.33M | $15.64M | 2.03% |
| Mar 26, 2021 | Dec 2020 | $6.88M | $6.14M | -10.80% |
| Dec 31, 2019 | Dec 2019 | $2.76M | $2.32M | -16.01% |
| Mar 31, 2019 | Dec 2018 | $21.12M | $4.79M | -77.33% |
| Mar 21, 2018 | Dec 2017 | - | $479.92K | - |
| Mar 28, 2017 | Dec 2016 | - | $75.91K | - |
| Mar 29, 2016 | Dec 2015 | - | $0.00 | - |
CLGN's next earnings date is Wednesday, May 25, 2022 for the fiscal quarter ending Mar 31, 2022.
According to 1 analysts, the average EPS estimation for Collplant Biotechnologies Ltd's next quarterly earnings is $-0.14, with a low EPS estimation of $-0.14, and a high estimation of $-0.14.
Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $0.48, the last 2 month trend is $0.48, and the 3 month trend is $0.48.
Based on 1 analysts, the average revenue estimation is $2.74M, with a low revenue estimation of $2.74M, and a high estimation of $2.74M.
Collplant Biotechnologies Ltd's previous earnings date was Mar 24, 2022 for its fiscal quarter ended Dec 31, 2021.
CLGN's earnings per share (EPS) was $-0.30, missing the consensus analysts forecast of $-0.29 by -3.45%.
The EPS was lower than the previous fiscal quarter (Sep 2021) by 3.45%, and higher than the same period a year before (Dec 2020) by -28.57%.
Revenues were $310.00K.
The company reported a net income of $-3.77M.Free cash flow for the quarter was $-2.93M , compared to $-3.45M last quarter and $-1.74M a year before.
Collplant Biotechnologies Ltd's previous annual earnings date was Mar 24, 2022 for its fiscal year ended Dec 31, 2021.
CLGN's earnings per share (EPS) was $-0.01, missing the consensus analysts forecast of $0.32 by -103.13% , and higher than the previous year's EPS (Dec 2020) by -99.29%.
Revenues were $15.64M, better than the forecast of $15.33M by 2.03%, and up by 154.86% from previous year's revenue.
The company reported a net income of $237.00K.
Collplant Biotechnologies Ltd reported a free cash flow of $912.00K for its fiscal year, compared to $-4.97M a year ago.
The company ended the fiscal year with $3.61M in total debt, an increase of 6.49% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
